Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
Bhalla
A K
AK
Samaranayaka
M
M
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D017410:Practice Guidelines as Topic
D018501:Antirheumatic Agents